Sandrine Aspeslagh

Universitair Ziekenhuis Brussel
Brussels, BRU, BE 
Universitair Ziekenhuis Brussel
Brussels, BRU, BE 

Overview

Sandrine Aspeslagh practices practicing medicine in Brussels, Belgium.

Her clinical expertise encompasses Melanoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Endometrial Cancer, Tissue Biopsy, and Kidney Transplant.

She is actively involved in clinical research, co-authoring 89 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Universitair Ziekenhuis Brussel
Brussels, BRU, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Efficacy of Olaparib in Advanced Cancers Occurring in Patients With Germline Mutations or Somatic Tumor Mutations in Homologous Recombination Genes
Efficacy of Olaparib in Advanced Cancers Occurring in Patients With Germline Mutations or Somatic Tumor Mutations in Homologous Recombination Genes
Enrollment Status: Unknown
Publish Date: August 19, 2024
Intervention Type: Drug
Study Drug: Olaparib
Study Phase: Phase 2
A Phase 1a/1b Study of an Anti-IDO-1 Agent (LY3381916) Administered Alone or in Combination With Anti- PD-L1 Checkpoint Antibody (LY3300054) in Solid Tumors
A Phase 1a/1b Study of an Anti-IDO-1 Agent (LY3381916) Administered Alone or in Combination With Anti- PD-L1 Checkpoint Antibody (LY3300054) in Solid Tumors
Enrollment Status: Terminated
Publish Date: June 09, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 1 Less Clinical Trial

89 Total Publications

Three-year analysis of the Belgian multidisciplinary immunotoxicity (BITOX) board: organization, feasibility, and results.
Three-year analysis of the Belgian multidisciplinary immunotoxicity (BITOX) board: organization, feasibility, and results.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026

Frequently Asked Questions about Sandrine Aspeslagh

Is Sandrine Aspeslagh a top-rated expert for Melanoma?

MediFind is an objective health platform that identifies experts based on real-world data. Sandrine Aspeslagh is classified as an Experienced expert for Melanoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sandrine Aspeslagh participate in research or clinical trials?

Yes. Sandrine Aspeslagh has published 89 articles and abstracts on conditions like Melanoma. You can view a list of Sandrine Aspeslagh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Aspeslagh's expertise for a condition
ConditionClose
        View All 24 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile